Tevogen Bio Holdings Inc.
TVGN
$7.00
-$2.54-26.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -32.52% | 28.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.15% | -19.53% | |||
| Operating Income | -17.15% | 19.53% | |||
| Income Before Tax | -16.43% | 18.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.43% | 18.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.43% | 18.32% | |||
| EBIT | -17.15% | 19.53% | |||
| EBITDA | -17.98% | 20.54% | |||
| EPS Basic | 31.26% | -56.86% | |||
| Normalized Basic EPS | 31.40% | -55.91% | |||
| EPS Diluted | 31.26% | -56.86% | |||
| Normalized Diluted EPS | 31.40% | -55.91% | |||
| Average Basic Shares Outstanding | 69.72% | -47.61% | |||
| Average Diluted Shares Outstanding | 69.72% | -47.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||